These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11147669)

  • 21. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the molecular control of the lymphatic vascular system and its role in disease.
    Cueni LN; Detmar M
    J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.
    Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R
    Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.
    Goldman J; Le TX; Skobe M; Swartz MA
    Circ Res; 2005 Jun; 96(11):1193-9. PubMed ID: 15890974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.
    Hong YK; Harvey N; Noh YH; Schacht V; Hirakawa S; Detmar M; Oliver G
    Dev Dyn; 2002 Nov; 225(3):351-7. PubMed ID: 12412020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue engineering and regeneration of lymphatic structures.
    Weitman E; Cuzzone D; Mehrara BJ
    Future Oncol; 2013 Sep; 9(9):1365-74. PubMed ID: 23980683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology.
    Witte MH; Bernas MJ; Martin CP; Witte CL
    Microsc Res Tech; 2001 Oct; 55(2):122-45. PubMed ID: 11596157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
    Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
    FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic vessels in cancer metastasis: bridging the gaps.
    Shayan R; Achen MG; Stacker SA
    Carcinogenesis; 2006 Sep; 27(9):1729-38. PubMed ID: 16597644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lymphatic system in the dorsal skinfold chamber of the Syrian golden hamster in vivo.
    Schacht V; Berens von Rautenfeld D; Abels C
    Arch Dermatol Res; 2004 May; 295(12):542-8. PubMed ID: 15034721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.
    Wigle JT; Harvey N; Detmar M; Lagutina I; Grosveld G; Gunn MD; Jackson DG; Oliver G
    EMBO J; 2002 Apr; 21(7):1505-13. PubMed ID: 11927535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphangiogenesis in tumors: what do we know?
    Reis-Filho JS; Schmitt FC
    Microsc Res Tech; 2003 Feb; 60(2):171-80. PubMed ID: 12539171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.
    Nakamura K; Rockson SG
    Lymphat Res Biol; 2008; 6(3-4):181-9. PubMed ID: 19093791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice.
    Qu X; Tompkins K; Batts LE; Puri M; Baldwin HS
    Development; 2010 Apr; 137(8):1285-95. PubMed ID: 20223757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paralemmin-1 is expressed in lymphatic endothelial cells and modulates cell migration, cell maturation and tumor lymphangiogenesis.
    Albrecht I; Bieri R; Leu A; Granacher P; Hagmann J; Kilimann MW; Christofori G
    Angiogenesis; 2013 Oct; 16(4):795-807. PubMed ID: 23709172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphangioblasts in embryonic lymphangiogenesis.
    Wilting J; Tomarev SI; Christ B; Schweigerer L
    Lymphat Res Biol; 2003; 1(1):33-40. PubMed ID: 15624319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.